Is polycystic ovary syndrome a 20th Century phenomenon?
- PMID: 30798911
- DOI: 10.1016/j.mehy.2019.01.019
Is polycystic ovary syndrome a 20th Century phenomenon?
Abstract
Polycystic ovary syndrome (PCOS) affects around 10% of women of reproductive age and is most common in developed countries. The aetiology of PCOS is not completely understood. Current evidence suggests that the syndrome results from a genetic predisposition interacting with developmental events during fetal or perinatal life that together increase susceptibility in some individuals. This implies that environmental factors influence the initiation of PCOS in the fetus or infant, either directly or via the mother. PCOS is often considered to be an ancient disorder but there is no direct proof of this in the medical or historic record. One of the cardinal features, polycystic ovaries, was first described only in the early 1900s, despite reports of many thousands of autopsies recorded earlier. This conundrum could be explained by postulating that polycystic ovaries were rare before the 1900s and have become more common over the last 100 years. The hypothesis that PCOS is a syndrome of the 20th Century would eliminate the need to explain the paradox of why there exists a genetic predisposition to subfertility syndrome.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Development of polycystic ovary syndrome: involvement of genetic and environmental factors.Int J Androl. 2006 Feb;29(1):278-85; discussion 286-90. doi: 10.1111/j.1365-2605.2005.00623.x. Epub 2005 Dec 22. Int J Androl. 2006. PMID: 16390494 Review.
-
Is foetal hyperexposure to androgens a cause of PCOS?Hum Reprod Update. 2017 Jul 1;23(4):421-432. doi: 10.1093/humupd/dmx013. Hum Reprod Update. 2017. PMID: 28531286 Review.
-
[Genetic aspects of polycystic ovary syndrome].Endokrynol Pol. 2005 May-Jun;56(3):285-93. Endokrynol Pol. 2005. PMID: 16350721 Review. Polish.
-
Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.J Clin Endocrinol Metab. 2006 May;91(5):1660-6. doi: 10.1210/jc.2005-2757. Epub 2006 Mar 7. J Clin Endocrinol Metab. 2006. PMID: 16522691 Review.
-
Epilepsy and polycystic ovary syndrome: where is the link?Neurol Sci. 2006 Sep;27(4):221-30. doi: 10.1007/s10072-006-0675-y. Neurol Sci. 2006. PMID: 16998724 Review.
Cited by
-
Adiponectin Reduces Embryonic Loss Rate and Ameliorates Trophoblast Apoptosis in Early Pregnancy of Mice with Polycystic Ovary Syndrome by Affecting the AMPK/PI3K/Akt/FoxO3a Signaling Pathway.Reprod Sci. 2020 Dec;27(12):2232-2241. doi: 10.1007/s43032-020-00237-z. Epub 2020 Jun 25. Reprod Sci. 2020. PMID: 32588392 Free PMC article.
-
Insights into Vitamin E with Combined Oral Contraceptive on INSR Gene in PCOS by Integrating In Silico and In Vivo Approaches.Appl Biochem Biotechnol. 2024 Jun;196(6):2990-3009. doi: 10.1007/s12010-023-04710-8. Epub 2023 Aug 23. Appl Biochem Biotechnol. 2024. PMID: 37610513
-
Jujuboside A Attenuates Polycystic Ovary Syndrome Based on Estrogen Metabolism Through Activating AhR-mediated CYP1A2 Expression.Reprod Sci. 2024 Aug;31(8):2234-2245. doi: 10.1007/s43032-024-01511-0. Epub 2024 Mar 18. Reprod Sci. 2024. PMID: 38499949
-
Therapeutic potential of 3-acetyl coumarin against polycystic ovarian syndrome induced by letrozole using female rats.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):7057-7074. doi: 10.1007/s00210-024-03720-5. Epub 2024 Dec 23. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39715882
-
Aberrant activation of the Hedgehog signaling pathway in granulosa cells from patients with polycystic ovary syndrome.Bioengineered. 2021 Dec;12(2):12123-12134. doi: 10.1080/21655979.2021.2003943. Bioengineered. 2021. PMID: 34873972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical